SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen South African Variant with B.1.351 RBD Mutations (1 mg)

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. Spike protein of the mutant strain B.1.351, also commonly known as the “South Africa Variant”. It is a full-length protein, which is active in its native trimeric form, that is stabilized in LMNG detergent.

SA Variant w B.1.351 RBD Mutations_Datasheet

Features

Product Name: SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen (South African Variant)
WHO Label: Beta
UniProt Number: P0DTC2
SARS-CoV-2 Protein: South African Mutation B.1.351
Host: HEK293
Mutations that differ from SPIKE Protein: del 144, K417N, E484K, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
Further Modifications: Furin cleavage site “RRAR” mutated to “GSAG”; K986P V987P
Buffer Composition: 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG
Molecular Weight (Trimeric): 3 x 142 kDa = 426 kDa